Quetiapine
Product Images NDC 50090-1733

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 50090-1733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500901733)

Label Image (Lbl500901733)
Quetiapine 400 mg tablets packaging label from A-S Medication Solutions. The label states each film-coated tablet contains quetiapine fumarate equivalent to 400 mg of quetiapine. Storage instructions specify to keep at 77 degrees Fahrenheit. The package contains 30 tablets. The product number is 6602-0 and the NDC is 50090-1733-0. The labeler address is Libertyville, IL 60048.*
FDA Label Image

Label Image (Lbl500902307)

Label Image (Lbl500902307)
Quetiapine 25 mg tablet bottle label from A-S Medication Solutions. The label includes dosage strength, quantity of 30 tablets, storage instructions to store at 77 degrees Fahrenheit, and dosage form as film-coated tablets. It also references the NDC number 50090-2307-0 and includes directions to see the package insert for dosage information.*
FDA Label Image

Label Image (Lbl500902420)

Label Image (Lbl500902420)
Quetiapine 200 mg film-coated tablet bottle label by A-S Medication Solutions. The label includes product and lot numbers, storage instructions to keep below 77 degrees Fahrenheit, and indicates the package contains 30 tablets. The label instructs users to see the package insert for dosing information.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A line graph showing the proportion of patients with relapse (%) over time in weeks, comparing two groups labeled QTP + LIVAL and PLA + LIVAL. The x-axis represents time in weeks up to 100, and the y-axis represents the percentage of patients relapsing from 0 to 100%. The graph illustrates trends of patient relapse rates for the two groups throughout the study period.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A line graph showing the proportion of patients with relapse (%) over time in weeks up to 100 weeks. The graph compares two groups: one with treatment labeled as QTP + LI/VAL and the other as PLA + LI/VAL, with the QTP + LI/VAL group showing a lower relapse proportion over time.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure diagram of Quetiapine, showing its molecular components and two associated counterions. The structure includes ring systems with nitrogen, sulfur, oxygen atoms and functional groups consistent with quetiapine's chemical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.